PTAB Designates as Precedential a Decision on the PTAB’s Discretion to Deny Institution of an IPR Based on a Parallel District Court Proceeding

May 20, 2020

Reading Time : 4 min

The Patent Trial and Appeal Board (PTAB) recently designated an order, Apple Inc. v. Fintiv, Inc., IPR 2020-00019, Paper 11 (Mar. 20, 2020), as precedential. The order outlines six non-dispositive factors the PTAB will consider when determining whether to exercise its discretion under 35 U.S.C. § 314(a) to deny institution of an inter partes review (IPR) based on parallel proceedings.

Patent owner Fintiv sued Apple, alleging infringement of U.S. Patent No. 8,843,125 (“the ’125 patent”). Apple filed a petition challenging claims of the ’125 patent and argued that, despite a parallel district court proceeding involving the same invalidity challenges, the PTAB should not exercise its authority to deny institution because no trial date had been set. Following the filing of the petition, however, the district court entered a scheduling order that set a trial date before the projected deadline for a final written decision in the IPR.

Focusing on efficiency, fairness, and merits, the PTAB has laid out the factors it will consider when deciding whether to exercise its authority to deny institution in view of the parallel district court proceeding and requested the parties to submit further briefing.

The Factors to be Assessed by the PTAB:

1. Whether the court granted a stay or evidence exists that one may be granted if a proceeding is instituted

A district court stay of the parallel proceeding can weigh strongly against denying institution because it allays concerns about inefficiency and duplication of efforts. Evidence that a stay may be granted includes a denial of stay without prejudice with leave to file a renewed motion if the PTAB trial is instituted. Conversely, a denial of a stay with no indication that the court will consider a renewed motion can weigh in favor of denying institution. When there is a parallel International Trade Commission (ITC) investigation, the PTAB instructs parties to indicate whether there is also a stayed parallel district court case and whether the patentability disputes before the ITC will resolve substantially all of the patentability disputes between the parties.

2. Proximity of the court’s trial date to the Board’s projected statutory deadline for a final written decision

A district court trial date that is before the PTAB’s statutory deadline for the final written decision weighs in favor of denying institution. A trial date at or around the statutory deadline, or even significantly later, will likely implicate other factors, such as the resources that have been invested in the parallel proceeding.

3. Investment in the parallel proceeding by the court and the parties 

The PTAB also considers the amount and type of work already completed in the parallel proceeding, by both the court and the parties. Substantive orders concerning the patent-at-issue, such as a claim construction order, may favor denial. The lack of orders related to the patent weighs against denial of institution.

The PTAB instructs parties to explain facts relevant to timing of the petition’s filing. If the petitioner files its petition promptly after learning which claims are asserted in the parallel proceeding, this weighs against denying institution. On the other hand, if the petitioner did not file expeditiously, or cannot explain a delay in filing, these facts can favor denial.

4. Overlap between issues raised in the petition and in the parallel proceeding

 Concerns of inefficiency and possible conflicting decisions are particularly strong where the petition presents substantially identical arguments that were at issue in the district court. Thus, this fact favors denial. Conversely, a petition presenting materially different arguments or evidence than those provided in the district court tends to weigh against denial. Weighing the degree of similarity is fact dependent. The PTAB instructs parties to indicate whether all or some of the claims challenged in the petition are also at issue in the district court. Non-overlapping claim challenges in the petition will weigh for or against denial of institution, depending on their similarity to the claims at issue in district court.

5. Whether the petitioner and the defendant in the parallel proceeding are the same party

If a petitioner is unrelated to a defendant in an earlier proceeding, this fact weighs against exercising discretion to deny institution. However, even if the petitioner is unrelated, the PTAB instructs petitioners to discuss other proceedings involving the challenged patent and explain why addressing the same or substantially the same issues would not be duplicative of the earlier proceeding.

6. Other circumstances that impact the Board’s exercise of discretion, including the merits

The PTAB considers all relevant circumstances in deciding whether to exercise its discretion to deny institution. Accordingly, in addition to the five factors above, other circumstances, such as the merit of the grounds raised in the petition, will also be evaluated.

Practice Tip: Assessing these six factors should be part of strategic considerations by the parties litigating before the PTAB where there is an ongoing parallel district court litigation. Timing can be critical, and petitioners should file their petitions as early as possible, highlighting any differences between the issues in the district court proceeding and those in the petition. Patent owners in parallel proceedings should address these factors when seeking a discretionary denial of institution in their preliminary response.

Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 (Mar. 20, 2020) (Precedential)

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.